RESUMO
OBJECTIVES: To characterize the utility of nitrotyrosine (NT) as a biomarker for arthritis and joint injury. DESIGN: Synovial fluid, plasma, and urine from patients diagnosed with osteoarthritis (OA), rheumatoid arthritis (RA), anterior cruciate ligament (ACL) injury, meniscus injury and pseudogout, and knee-healthy volunteers were analyzed for concentrations of NT, nitrate and nitrite (NO(x)), matrix metalloproteinase (MMP)-3, MMP-1, MMP-9, more than 40 chemokines and cytokines. RESULTS: In OA, plasma and synovial fluid NT were increased versus healthy volunteers. Synovial fluid to plasma NT ratios were elevated in OA patients. Synovial fluid from patients with ACL and meniscus injury and pseudogout had increased levels of NT (P < 0.001). In these samples, NT levels significantly correlated with ARGS-aggrecan neoepitope generated by aggrecanase cleavage of aggrecan (P ≤ 0.001), cross-linked C-telopeptides of type II collagen (P < 0.001), MMP-1 (P = 0.008), and MMP-3 (P ≤ 0.001). In RA, plasma NT decreased following 6 months of anti-tumor necrosis factor (TNF) treatment. For every 1.1% change in log(10) NT, there was a 1.0% change in the log(10) disease activity scores (DAS28-3 CRP). Both predicted and observed DAS28-3 CRP showed a robust linear relationship with NT. RA plasma NT positively correlated with CRP, MMP-3 and interferon γ-induced protein 10. CONCLUSIONS: NT may serve as a useful biomarker for arthritis and joint injury. In RA, NT is highly correlated with several biomarkers and clinical correlates of disease activity and responds to anti-TNF therapy.
Assuntos
Ligamento Cruzado Anterior/metabolismo , Artrite Reumatoide/metabolismo , Condrocalcinose/metabolismo , Meniscos Tibiais/metabolismo , Osteoartrite do Joelho/metabolismo , Lesões do Ligamento Cruzado Anterior , Estudos de Casos e Controles , Quimiocinas/metabolismo , Citocinas/metabolismo , Feminino , Humanos , Masculino , Metaloproteinases da Matriz Secretadas/metabolismo , Nitratos/metabolismo , Líquido Sinovial/metabolismo , Lesões do Menisco Tibial , Tirosina/análogos & derivados , Tirosina/metabolismoRESUMO
The role of nitric oxide in the immune response to allogeneic tissue was explored in an in vivo cardiac transplant model in the rat. Nitric oxide production during organ rejection was demonstrated by elevations in systemic serum nitrite/nitrate levels and by electron paramagnetic resonance spectroscopy. Messenger RNA for the inducible nitric oxide synthase enzyme was detected in the rejecting allografted heart, but not in the nonrejecting isografted heart. The enzyme was demonstrated to be biologically active by the in vitro conversion of L-arginine to L-citrulline and was immunohistochemically localized to the infiltrating inflammatory cells. Treatment with aminoguanidine, a preferential inhibitor of the inducible nitric oxide synthase isoform, prevented the increased nitric oxide production in the transplanted organ and significantly attenuated the pathogenesis of acute rejection. Aminoguanidine treatment prolonged graft survival, improved graft contractile function, and significantly reduced the histologic grade of rejection. These results suggest an important role for nitric oxide in mediating the immune response to allogeneic tissue. Inhibition of inducible nitric oxide synthase may provide a novel therapeutic modality in the management of acute transplant rejection and of other immune-mediated processes.
Assuntos
Aminoácido Oxirredutases/antagonistas & inibidores , Rejeição de Enxerto , Transplante de Coração , Óxido Nítrico/fisiologia , Sequência de Aminoácidos , Animais , Sequência de Bases , Primers do DNA/química , Indução Enzimática/efeitos dos fármacos , Expressão Gênica , Guanidinas/farmacologia , Dados de Sequência Molecular , Óxido Nítrico Sintase , RNA Mensageiro/genética , Ratos , Ratos Endogâmicos ACI , Ratos Endogâmicos LewRESUMO
Many human diseases are associated with the overproduction of oxygen free radicals that inflict cell damage. A manganese(II) complex with a bis(cyclohexylpyridine)-substituted macrocyclic ligand (M40403) was designed to be a functional mimic of the superoxide dismutase (SOD) enzymes that normally remove these radicals. M40403 had high catalytic SOD activity and was chemically and biologically stable in vivo. Injection of M40403 into rat models of inflammation and ischemia-reperfusion injury protected the animals against tissue damage. Such mimics may result in better clinical therapies for diseases mediated by superoxide radicals.
Assuntos
Anti-Inflamatórios não Esteroides/uso terapêutico , Inflamação/tratamento farmacológico , Compostos Organometálicos/toxicidade , Traumatismo por Reperfusão/tratamento farmacológico , Superóxido Dismutase , Superóxidos/metabolismo , Animais , Anti-Inflamatórios não Esteroides/síntese química , Anti-Inflamatórios não Esteroides/química , Anti-Inflamatórios não Esteroides/metabolismo , Citoproteção , Dinoprostona/metabolismo , Relação Dose-Resposta a Droga , Desenho de Fármacos , Estabilidade de Medicamentos , Interleucina-1/metabolismo , L-Lactato Desidrogenase/metabolismo , Masculino , Manganês , Mimetismo Molecular , Neutrófilos/efeitos dos fármacos , Compostos Organometálicos/síntese química , Compostos Organometálicos/química , Compostos Organometálicos/metabolismo , Ratos , Ratos Sprague-Dawley , Circulação Esplâncnica , Superóxido Dismutase/metabolismo , Fatores de Tempo , Fator de Necrose Tumoral alfa/metabolismoRESUMO
Chicken nerve growth factor (NGF) receptor cDNAs have been isolated and sequenced in an effort to identify functionally important receptor domains and as an initial step in determining the functions of the NGF receptor in early embryogenesis. Comparisons of the primary amino acid sequences of the avian and mammalian NGF receptors have identified several discrete domains that differ in their degree of conservation. The highly conserved regions include an extracellular domain, likely to be involved in ligand binding, in which the positions of 24 cysteine residues and virtually all negatively charged residues are conserved; a transmembrane region, including flanking stretches of extracellular and cytoplasmic amino acids, which has properties suggesting it interacts with other proteins; and a cytoplasmic PEST sequence, which may regulate receptor turnover. Transient expression of NGF receptor mRNA has been seen in many regions of the developing CNS. Experiments suggest that both NGF and its receptor help regulate development of the retina.
Assuntos
Encéfalo/metabolismo , Fatores de Crescimento Neural/fisiologia , Receptores de Superfície Celular/genética , Medula Espinal/metabolismo , Sequência de Aminoácidos , Animais , Sequência de Bases , Galinhas , DNA/genética , Sondas de DNA , Biblioteca Gênica , Humanos , Immunoblotting , Dados de Sequência Molecular , RNA Mensageiro/genética , Ratos , Receptores de Fator de Crescimento Neural , Mapeamento por Restrição , Homologia de Sequência do Ácido NucleicoRESUMO
Hybridization probes from the transmembrane region of the chick NGF receptor (NGF-R) that show high homology with the rat NGF-R were used to demonstrate an abundant 4.5 kb NGF-R mRNA in the chick embryo at E3.5. The level remained high until E12 but decreased to adult levels by E18. The highest levels at E8 were in spinal cord, bursa of Fabricius, gizzard, femoralis muscle, and skin. In situ hybridization to E7 embryos showed high expression of the NGF-R gene in spinal cord, particularly the lateral motor column, and in dorsal root, sympathetic, and nodose ganglia. NGF-R mRNA expression was observed throughout brain development and in all regions of the adult brain, with high levels in cerebellum and septum. Lymphoid tissues of chick and rat also expressed the receptor. The complex and widespread expression of NGF-R mRNA in areas not known to be NGF targets suggests broader functions for NGF.
Assuntos
RNA Mensageiro/genética , Receptores de Superfície Celular/genética , Sequência de Aminoácidos , Animais , Sequência de Bases , Encéfalo/metabolismo , Encéfalo/ultraestrutura , Bolsa de Fabricius/metabolismo , Bolsa de Fabricius/ultraestrutura , Embrião de Galinha , Expressão Gênica , Sistema Imunitário/fisiologia , Linfonodos/metabolismo , Linfonodos/ultraestrutura , Dados de Sequência Molecular , Músculos/metabolismo , Músculos/ultraestrutura , Hibridização de Ácido Nucleico , RNA Mensageiro/metabolismo , Ratos , Ratos Endogâmicos , Receptores de Superfície Celular/fisiologia , Receptores de Fator de Crescimento Neural , Pele/metabolismo , Pele/ultraestrutura , Medula Espinal/metabolismo , Medula Espinal/ultraestrutura , Baço/metabolismo , Baço/ultraestrutura , Timo/metabolismo , Timo/ultraestruturaRESUMO
Treatment of primary cultures of rat ovarian dispersates with IL-1 beta results in morphologic and cytotoxic changes, thought to reflect tissue remodeling events associated with ovulation. We examined the role that the free radical nitric oxide plays in this process and report that IL-1 beta induces expression of the inducible isoform of nitric oxide synthase in ovarian cells as demonstrated by immunoprecipitation. We show that IL-1 beta treatment results in the formation of nitric oxide (as measured by accumulation of nitrite and cGMP) in both a time- and concentration-dependent manner that is prevented by aminoguanidine, a selective inhibitor of the inducible isoform of nitric oxide synthase. Aminoguanidine also inhibits IL-1-induced ovarian cellular cytotoxicity. These results suggest that nitric oxide is an important mediator of cell death and may act as a physiologically significant mediator of tissue remodeling events that occur in vivo during the ovulatory process.
Assuntos
Aminoácido Oxirredutases/biossíntese , Morte Celular/fisiologia , Interleucina-1/farmacologia , Isoenzimas/biossíntese , Óxido Nítrico/fisiologia , Ovário/fisiologia , Ovulação/fisiologia , Animais , Morte Celular/efeitos dos fármacos , Células Cultivadas , GMP Cíclico/metabolismo , Indução Enzimática , Feminino , Humanos , Interleucina-1/toxicidade , Óxido Nítrico/metabolismo , Óxido Nítrico Sintase , Nitritos/metabolismo , Ovário/citologia , Ovário/efeitos dos fármacos , Ratos , Ratos Sprague-Dawley , Proteínas Recombinantes/farmacologia , Proteínas Recombinantes/toxicidadeRESUMO
Previous work from our laboratory localized nitric oxide to the affected spinal cords of mice with experimental autoimmune encephalomyelitis, a prime model for the human disease multiple sclerosis. The present study shows that activated lymphocytes sensitized to the central nervous system encephalitogen, myelin basic protein, can induce nitric oxide production by a murine macrophage cell line. Induction was inhibited by amino-guanidine, a preferential inhibitor of the inducible nitric oxide synthase isoform, and by NG-monomethyl-L-arginine. Aminoguanidine, when administered to mice sensitized to develop experimental autoimmune encephalomyelitis, inhibited disease expression in a dose-related manner. At 400 mg aminoguanidine/kg per day, disease onset was delayed and the mean maximum clinical score was 0.9 +/- 1.2 in aminoguanidine versus 3.9 +/- 0.9 in placebo-treated mice. Histologic scoring of the spinal cords for inflammation, demyelination, and axonal necrosis revealed significantly less pathology in the aminoguanidine-treated group. The present study implicates excessive nitric oxide production in the pathogenesis of murine inflammatory central nervous system demyelination, and perhaps in the human disease multiple sclerosis.
Assuntos
Aminoácido Oxirredutases/antagonistas & inibidores , Encefalomielite Autoimune Experimental/prevenção & controle , Guanidinas/farmacologia , Animais , Encefalomielite Autoimune Experimental/etiologia , Encefalomielite Autoimune Experimental/patologia , Feminino , Camundongos , Nitratos/sangue , Óxido Nítrico/fisiologia , Óxido Nítrico Sintase , Nitritos/sangue , Medula Espinal/patologiaRESUMO
The interaction between nitric oxide (NO) and cyclooxygenase (COX) was studied in a rabbit model of renal inflammation, the ureteral obstructed hydronephrotic kidney (HNK). Ex vivo perfusion of the HNK but not the control kidney (e.g., unobstructed contralateral kidney, CLK), led to a time-dependent release of nitrite (NO2-), a breakdown product of NO. Stimulation of the HNK with bradykinin (BK) evoked a time-dependent increase in prostaglandin E2 (PGE2) production. NG-monomethyl-L-arginine (L-NMMA), which blocks the activity of both constitutive and inducible nitric oxide synthase (cNOS and iNOS), aminoguanidine, a recently described selective iNOS inhibitor, dexamethasone, or cycloheximide abolished the release of NO2- and attenuated the exaggerated BK-induced PGE2 production. This supports the existence of iNOS and COX-2 in the HNK. In the CLK, BK elicited release of both NO2- and PGE2 but this did not augment with time. L-NMMA but not aminoguanidine, dexamethasone, or cycloheximide attenuated NO2- and PGE2 release indicative of the presence of constitutive but not inducible NOS or COX. The current study suggests that the endogenous release of NO from cNOS in the CLK activates a constitutive COX resulting in optimal PGE2 release by BK. In addition, in the HNK, NO release from iNOS activates the induced COX resulting in markedly increased release of proinflammatory prostaglandin. The broader implication of this study is that the cyclooxygenase isozymes are potential receptor targets for nitric oxide.
Assuntos
Dinoprostona/biossíntese , Hidronefrose/metabolismo , Rim/metabolismo , Óxido Nítrico/metabolismo , Nitritos/metabolismo , Aminoácido Oxirredutases/antagonistas & inibidores , Animais , Arginina/análogos & derivados , Arginina/metabolismo , Ácidos Cólicos/farmacologia , Modelos Animais de Doenças , Técnicas In Vitro , Indometacina/farmacologia , Rim/efeitos dos fármacos , Masculino , Modelos Biológicos , Óxido Nítrico Sintase , Perfusão , Prostaglandina-Endoperóxido Sintases/metabolismo , Coelhos , Ureter/cirurgia , ômega-N-MetilargininaRESUMO
This study was undertaken to compare the ability of two guanidine compounds (aminoguanidine and methylguanidine), with different in vitro effects on NO synthase activity and AGE formation, to inhibit diabetic vascular dysfunction developing early after the onset of diabetes. In rats with STZ-induced diabetes of 5-wk duration, regional vascular [125I]albumin permeation was increased about two- to threefold in ocular tissues, sciatic nerve, and aorta; in general, both guanidine compounds normalized albumin permeation in diabetic rats without affecting it in controls. Methylguanidine was only approximately 7% as effective as aminoguanidine as an inhibitor of AGE formation from L-lysine and G6P; both compounds were poor inhibitors of AR. Methylguanidine was approximately 1-5% as potent as aminoguanidine and L-NMMA as an inhibitor of the cytokine- and endotoxin-inducible isoform of NO synthase. In contrast, the potency of methylguanidine as an inhibitor of the constitutive isoform of NO synthase was comparable to that of aminoguanidine, and both guanidine compounds were much less effective than L-NMMA. These observations suggest a role for a relative or absolute increase in NO production in the pathogenesis of early diabetic vascular dysfunction and raise the possibility that inhibition of diabetic vascular functional changes by aminoguanidine may reflect inhibition of NO synthase activity rather than, or in addition to, prevention of AGE formation.
Assuntos
Aminoácido Oxirredutases/antagonistas & inibidores , Diabetes Mellitus Experimental/fisiopatologia , Angiopatias Diabéticas/prevenção & controle , Produtos Finais de Glicação Avançada/metabolismo , Guanidinas/uso terapêutico , Imidazolidinas , Metilguanidina/uso terapêutico , Aldeído Redutase/antagonistas & inibidores , Animais , Arginina/análogos & derivados , Arginina/farmacologia , Benzotiazóis , Pressão Sanguínea/efeitos dos fármacos , Peso Corporal/efeitos dos fármacos , Permeabilidade Capilar , Citrulina/análise , Diabetes Mellitus Experimental/sangue , Angiopatias Diabéticas/sangue , Angiopatias Diabéticas/fisiopatologia , Produtos Finais de Glicação Avançada/análise , Imidazóis/farmacologia , Inositol/metabolismo , Radioisótopos do Iodo , Masculino , Naftalenos/farmacologia , Óxido Nítrico Sintase , Ftalazinas/farmacologia , Ratos , Ratos Sprague-Dawley , Retina/efeitos dos fármacos , Retina/metabolismo , Nervo Isquiático/efeitos dos fármacos , Nervo Isquiático/metabolismo , Soroalbumina Bovina/metabolismo , Soroalbumina Bovina/farmacocinética , Sorbitol/metabolismo , Tiazóis/farmacologia , Úvea/efeitos dos fármacos , Úvea/metabolismo , ômega-N-MetilargininaRESUMO
Sensory neurons of the adult rat dorsal root ganglion (DRG) can be maintained in culture in the absence of nerve growth factor (NGF). We have thus used dissociated cultures of these neurons to study effects of NGF on the regulation of expression of mRNA encoding the nerve growth factor receptor (NGF-R). In the absence of NGF, levels of NGF-R mRNA remained constant for 7 days in cultures of adult rat DRG neurons. In the presence of NGF, NGF-R mRNA levels rose two - three-fold after 2 days, reaching plateau levels (five - six-fold elevation) after 5 days. This NGF-induced up-regulation could be demonstrated even after prior NGF-deprivation for 3 - 4 days. NGF had no effect upon NGF-R mRNA levels in DRG non-neuronal cells. Epidermal growth factor (EGF), fibroblast growth factor (FGF) and ciliary neurotrophic factor (CNTF) were without effect on NGF-R mRNA levels, but 8-bromo-cAMP decreased NGF-R mRNA levels by 65% after 2 days. NGF also induced a rapid (30 min) rise in expression of c-fos in DRG neurons, but not in non-neuronal cells. Our results suggest that endogenous levels of NGF may regulate the expression of NGF-R in vivo.
RESUMO
L-N6-(1-Iminoethyl)lysine (L-NIL) has been synthesized and is shown to be both a potent and selective inhibitor of mouse inducible nitric oxide synthase (miNOS). L-NIL has an IC50 of 3.3 microM for miNOS compared to an IC50 of 92 microM for rat brain constitutive NOS indicating that L-NIL is 28-fold more selective for inducible NOS. L-N5-(1-Iminoethyl)ornithine (L-NIO), which differs from L-NIL by having one less methylene group, has very similar potency for inducible NOS, but lacks selectivity. DL-N7-(1-Iminoethyl)homolysine was also synthesized and found to be substantially less potent than L-NIL or L-NIO, with intermediate selectivity for inducible NOS. These data suggest that L-NIL may be useful as a selective inhibitor of inducible NOS for determining the role of this enzyme in disease models.
Assuntos
Aminoácido Oxirredutases/antagonistas & inibidores , Lisina/análogos & derivados , Animais , Encéfalo/enzimologia , Lisina/farmacologia , Camundongos , Óxido Nítrico Sintase , RatosRESUMO
A series of 2-iminoazaheterocycles have been prepared and shown to be potent inhibitors of human nitric oxide synthase (NOS) isoforms. This series includes cyclic amidines ranging from five- to nine-membered rings, of which 2-iminopiperidine and 2-iminohomopiperidine were the most potent inhibitors, with IC50 values of 1.0 and 2.0 microM, respectively, for human inducible nitric oxide synthase. This series of cyclic inhibitors was further expanded to include analogs with heteroatoms in the 3-position of the six-membered ring. This modification was tolerated for sulfur and oxygen, but nitrogen reduced the inhibitory potency. The oral administration of 2-iminopiperidine in lipopolysaccharide (LPS)-treated rats inhibited the LPS-induced increase in plasma nitrite/nitrate levels in a dose-dependent manner, demonstrating its ability to inhibit inducible NOS activity in vivo. These cyclic amidines represent a new class of potent NOS inhibitors and the foundation for potential therapeutic agents.
Assuntos
Inibidores Enzimáticos/farmacologia , Compostos Heterocíclicos/farmacologia , Isoenzimas/antagonistas & inibidores , Óxido Nítrico Sintase/antagonistas & inibidores , Piperidinas/farmacologia , Animais , Inibidores Enzimáticos/química , Compostos Heterocíclicos/química , Humanos , Espectroscopia de Ressonância Magnética , Masculino , Piperidinas/química , Ratos , Ratos Endogâmicos LewRESUMO
An attractive approach to the treatment of inflammatory conditions such as osteo- and rheumatoid arthritis, inflammatory bowel disease, and sepsis is through the selective inhibition of human inducible nitric oxide synthase (hiNOS) since localized excess nitric oxide (NO) release has been implicated in the pathology of these diseases. A series of monosubstituted iminohomopiperidinium salts possessing lipophilic functionality at ring positions 3, 5, 6, and 7 has been synthesized, and series members have demonstrated the ability to inhibit the hiNOS isoform with an IC50 as low as 160 nM (7). Compounds were found that selectively inhibit hiNOS over the human endothelial constitutive enzyme (heNOS) with a heNOS/hiNOS IC50 ratio in excess of 100 and as high as 314 (9). Potencies for inhibition of hiNOS and the human neuronal constitutive enzyme (hnNOS) are comparable. Substitution in the 3 and 7 positions provides compounds that exhibit the greatest degree of selectivity for hiNOS and hnNOS over heNOS. Submicromolar potencies for 6 and 7 in a mouse RAW cell assay demonstrated the ability of these compounds to inhibit iNOS in a cellular environment. These latter compounds were also found to be orally bioavailable and efficacious due to their ability to inhibit the increase in plasma nitrite/nitrate levels in a rat LPS model.
Assuntos
Anti-Inflamatórios não Esteroides/farmacologia , Azepinas/farmacologia , Inibidores Enzimáticos/farmacologia , Iminas/farmacologia , Óxido Nítrico Sintase/antagonistas & inibidores , Administração Oral , Animais , Anti-Inflamatórios não Esteroides/administração & dosagem , Anti-Inflamatórios não Esteroides/síntese química , Anti-Inflamatórios não Esteroides/farmacocinética , Azepinas/administração & dosagem , Azepinas/síntese química , Azepinas/farmacocinética , Disponibilidade Biológica , Linhagem Celular , Indução Enzimática/efeitos dos fármacos , Inibidores Enzimáticos/administração & dosagem , Inibidores Enzimáticos/síntese química , Inibidores Enzimáticos/farmacocinética , Humanos , Iminas/administração & dosagem , Iminas/síntese química , Iminas/farmacocinética , Inflamação/sangue , Inflamação/induzido quimicamente , Lipopolissacarídeos/toxicidade , Macrófagos/efeitos dos fármacos , Macrófagos/enzimologia , Camundongos , Óxido Nítrico Sintase Tipo I , Óxido Nítrico Sintase Tipo II , Óxido Nítrico Sintase Tipo III , Ratos , Ratos Endogâmicos Lew , Proteínas Recombinantes/síntese química , Proteínas Recombinantes/farmacologia , Relação Estrutura-AtividadeRESUMO
Experimental autoimmune encephalomyelitis (EAE) is a T cell-mediated inflammatory demyelinating disorder of the central nervous system (CNS) which serves as a prime animal model for the human disease multiple sclerosis. Previous studies from these laboratories demonstrated excess nitric oxide (NO) in the CNS of EAE-affected mice, and amelioration of EAE with a selective inhibitor of the inducible nitric oxide synthase (iNOS). Recent studies from other laboratories have indicated that prostaglandin PGE2 is increased in CNS tissues of EAE-affected rodents and that EAE is prevented by the inhibition of cyclooxygenase activity. The present study investigated the ability of encephalitogenic lymphoid cells to induce NOS and cyclooxygenase (COX-2) in the murine macrophage line, RAW 264.7. In order to mimic the extracellular milieu present in EAE lesions, conditioned medium (CM) of activated EAE-inducer cells was added to this macrophage line. CM caused a time-dependent increase in nitrite, indicating NO production. Reverse-transcriptase PCR demonstrated iNOS mRNA in RAW 264.7 cells, first detected at 3 h, and Western blots confirmed the induction in RAW cells of the 130-kDa iNOS protein. Production of nitrite by CM-exposed RAW 264.7 cells was blocked by inhibitors of NOS (L-N-methylarginine or aminoguanidine) or by antibodies to murine IFN-gamma or IL-1 beta. CM of activated encephalitogenic cells induced production of PGE2 by RAW 264.7 cells, as determined by ELISA, and Western blots identified the presence of the 70-80-kDa inducible COX (COX-2) protein. Induction of COX-2 could be inhibited by antibody to IFN-gamma. Thus, encephalitogenic cells are capable of inducing the expression of the inflammatory enzymes iNOS and COX-2 in a murine macrophage line via the T cell cytokine IFN-gamma, alone or in combination with IL-1 beta.
Assuntos
Encefalomielite Autoimune Experimental/enzimologia , Inflamação/fisiopatologia , Interferon gama/fisiologia , Óxido Nítrico Sintase/biossíntese , Prostaglandina-Endoperóxido Sintases/biossíntese , Animais , Sequência de Bases , Células Cultivadas , Primers do DNA/química , Indução Enzimática , Feminino , Ativação de Macrófagos , Macrófagos/fisiologia , Camundongos , Camundongos Endogâmicos , Dados de Sequência MolecularRESUMO
Peroxynitrite, generated by the reaction of nitric oxide (NO) with superoxide at sites of inflammation, is a strong oxidant capable of damaging tissues and cells. Detection of nitrotyrosine (NT) at inflammatory sites serves as a biochemical marker for peroxynitrite-mediated damage. In this study, NT was detected immunohistochemically within autopsied CNS tissues from six of nine multiple sclerosis (MS) patients, and in most of the MS sections displaying inflammation. Nitrite and nitrate, the stable oxidation products of NO and peroxynitrite, respectively, were measured in cerebrospinal fluid samples obtained from MS patients and controls. Levels of nitrate were elevated significantly during clinical relapses of MS. These data suggest that peroxynitrite formation is a major consequence of NO produced in MS-affected CNS and implicate a role for this powerful oxidant in the pathogenesis of MS.
Assuntos
Sistema Nervoso Central/metabolismo , Esclerose Múltipla/metabolismo , Nitratos/metabolismo , Humanos , Imuno-Histoquímica , Inflamação/líquido cefalorraquidiano , Esclerose Múltipla/líquido cefalorraquidiano , Doenças do Sistema Nervoso/líquido cefalorraquidiano , Nitratos/líquido cefalorraquidiano , Nitritos/líquido cefalorraquidiano , Recidiva , Tirosina/análogos & derivados , Tirosina/metabolismoRESUMO
Peroxynitrite, which is generated by the reaction of nitric oxide (NO) with superoxide, is a strong oxidant that can damage subcellular organelles, membranes and enzymes through its actions on proteins, lipids, and DNA, including the nitration of tyrosine residues of proteins. Detection of nitrotyrosine (NT) serves as a biochemical marker of peroxynitrite-induced damage. In the present studies, NT was detected by immunohistochemistry in CNS tissues from mice with acute experimental autoimmune encephalomyelitis (EAE). NT immunoreactivity was displayed by many mononuclear inflammatory cells, including CD4+ cells. It was also observed in astrocytes near EAE lesions. Immunostaining for the inducible isoform of NO synthase (iNOS) was also observed, particularly during acute EAE. These data strongly suggest that peroxynitrite formation is a major consequence of NO produced via iNOS, and implicate this powerful oxidant in the pathogenesis of EAE.
Assuntos
Encefalomielite Autoimune Experimental/metabolismo , Encefalomielite Autoimune Experimental/patologia , Nitratos/metabolismo , Medula Espinal/metabolismo , Medula Espinal/patologia , Doença Aguda , Animais , Doença Crônica , Feminino , Imuno-Histoquímica , Camundongos , Camundongos Endogâmicos , Óxido Nítrico/metabolismo , Óxido Nítrico Sintase/análise , Recidiva , Indução de Remissão , Soroalbumina Bovina/metabolismo , Tirosina/análogos & derivados , Tirosina/análiseRESUMO
Peroxynitrite (PN), the product of nitric oxide (NO) reacted with superoxide, is generated at sites of inflammation. Nitrotyrosine (NT), a marker of PN formation, is abundant in lesions of acute experimental autoimmune encephalomyelitis (EAE), and in active multiple sclerosis (MS) plaques. To determine whether PN plays a role in EAE pathogenesis, mice induced to develop EAE were treated with a catalyst specific for the decomposition of PN. Because this catalyst has no effect upon NO, using it allowed differentiation of PN-mediated effects from NO-mediated effects. Mice receiving the PN decomposition catalyst displayed less severe clinical disease, and less inflammation and demyelination than control mice. Encephalitogenic T cells could be recovered from catalyst-treated mice, indicating that the PN decomposition catalyst blocked the pathogenic action of PN at the effector stage of EAE, but was not directly toxic to encephalitogenic T cells. PN plays an important role distinct from that of NO in the pathogenesis of EAE, a major model for MS.
Assuntos
Encefalomielite Autoimune Experimental/prevenção & controle , Compostos Férricos/farmacologia , Metaloporfirinas/farmacologia , Nitratos/metabolismo , Animais , Catálise , Sistema Nervoso Central/metabolismo , Encefalomielite Autoimune Experimental/patologia , Encefalomielite Autoimune Experimental/fisiopatologia , Feminino , Imuno-Histoquímica , Transfusão de Linfócitos , Linfócitos/imunologia , Camundongos , Camundongos Endogâmicos , Óxido Nítrico Sintase/metabolismo , Óxido Nítrico Sintase Tipo II , Tirosina/análogos & derivados , Tirosina/metabolismoRESUMO
We have recently demonstrated that (1) nitric oxide (NO) is produced during experimental cardiac allograft rejection by the expression of inducible nitric oxide synthase (iNOS) in the rejecting organ and that (2) inhibition of NO production by iNOS attenuated acute rejection. The present study examined the interaction of corticosteroids, iNOS gene expression, and iNOS enzyme activity in a rat cardiac transplant model. Increased NO production in rejecting allografts was demonstrated by elevated serum nitrite/nitrate levels (67 +/- 5 versus 18 +/- 2 microM for isografts; P < 0.001) that were significantly reduced by pulse therapy with dexamethasone for 2 days prior to animal sacrifice or continuous dexamethasone treatment (34 +/- 2 and 19 +/- 4 microM, respectively; P < 0.001 versus untreated allografts). Increased iNOS enzyme activity was demonstrated in the allograft heart (5.11 +/- 1.00 versus 0.3 +/- 0.05 pmol L-citrulline.mg protein-1.min-1 for isografts) and was significantly reduced with dexamethasone treatment (1.13 +/- 0.47 for 2-day pulse-treated allografts and 0.02 +/- 0.01 for continuously treated allografts). Increased allograft iNOS enzyme activity resulted from induction of iNOS mRNA expression, which was more than 99% inhibited by dexamethasone treatment. Dexamethasone pulse therapy reduced but did not eliminate the histological changes of acute rejection. Thus corticosteroid treatment results in inhibition of iNOS expression during allograft rejection. These results further demonstrate that iNOS expression during acute rejection is immune-mediated and suggest that the immunosuppressive actions of corticosteroids in the treatment of acute rejection may include inhibition of iNOS expression.
Assuntos
Corticosteroides/administração & dosagem , Rejeição de Enxerto/enzimologia , Transplante de Coração , Óxido Nítrico Sintase/antagonistas & inibidores , Animais , Ativação Enzimática/efeitos dos fármacos , Regulação Enzimológica da Expressão Gênica/efeitos dos fármacos , Óxido Nítrico Sintase/genética , Ratos , Ratos Endogâmicos ACI , Ratos Endogâmicos Lew , Transplante HomólogoRESUMO
BACKGROUND: We recently demonstrated that inhibition of inducible nitric oxide synthase (iNOS) ameliorated severe acute lung allograft rejection. This study used a rat lung transplant model to determine (1) the time course and cellular localization of iNOS expression during the histological progression of unmodified acute rejection and (2) whether inhibition of iNOS prevented impaired gas exchange function of the allograft lung and/or ameliorated the histological changes of acute rejection. METHODS AND RESULTS: iNOS mRNA and enzyme activity were expressed in allograft lungs during mild, moderate, and severe acute rejection, but not in normal, isograft, or allograft lungs before histological changes of mild acute rejection. iNOS expression in allografts resulted in elevated serum nitrite/nitrate levels, indicative of increased in vivo nitric oxide (NO) production. In situ hybridization demonstrated iNOS mRNA expression in infiltrating inflammatory cells, but not in allograft parenchymal cells. Allografts had significantly impaired gas exchange, which was prevented with the selective iNOS inhibitor aminoguanidine (PaO2 of 566+/-19, 76+/-22, and 504+/-105 mmHg for isograft, allograft, and aminoguanidine-treated allograft, respectively; P<0.0002). Aminoguanidine also significantly improved the histological rejection scores. CONCLUSIONS: (1) iNOS expression and increased NO production occurred during the early stages of acute rejection, persisted throughout the unmodified rejection process, and localized to infiltrating inflammatory cells, but not allograft parenchymal cells; (2) aminoguanidine ameliorated the histological and functional changes of acute rejection; and (3) increased NO production, detected by the presence of iNOS mRNA, protein, or noninvasively by measuring serum nitrite/nitrate levels, may serve as an early marker of acute allograft rejection.
Assuntos
Transplante de Pulmão/imunologia , Óxido Nítrico Sintase/antagonistas & inibidores , Doença Aguda , Animais , Expressão Gênica , Rejeição de Enxerto/patologia , Rejeição de Enxerto/fisiopatologia , Hibridização In Situ , Masculino , Óxido Nítrico Sintase/genética , Sondas RNA , RNA Antissenso/metabolismo , RNA Mensageiro/metabolismo , Ratos , Ratos Endogâmicos BN , Ratos Endogâmicos F344 , Transplante Homólogo/imunologia , Transplante Homólogo/patologiaRESUMO
Messenger RNA encoding inducible NO synthase (iNOS) was measured by competitive reverse transcriptase polymerase chain reaction (cRT-PCR) and ribonuclease protection assays in spinal cords from mice at varying stages of experimental allergic encephalomyelitis (EAE) and from control mice. iNOS mRNA was increased in spinal cords from mice with acute EAE. cRT-PCR assays revealed a 10-20-fold increase in iNOS mRNA in spinal cords during acute EAE compared with the level observed in normal mouse spinal cords. Functional iNOS activity, as assessed by assay of calcium-independent citrulline production, was also significantly increased in spinal cords from mice with acute EAE in comparison to normal controls. The correlation of functional iNOS expression with active disease in EAE in consistent with a pathogenic role for excess NO in this model of cell-mediated central nervous system autoimmunity.